{ "cik": 874015, "cik_padded": "0000874015", "entityName": "IONIS PHARMACEUTICALS INC", "fiscal_years": [ { "accn": "0000874015-26-000115", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 51444000.0, "cash": 372260000.0, "eps_diluted": -2.38, "free_cash_flow": -320027000.0, "net_income": -381387000.0, "operating_cash_flow": -268583000.0, "operating_income": -381684000.0, "revenue": 943711000.0, "stockholders_equity": 489089000.0, "total_assets": 3523836000.0, "total_liabilities": 3034747000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 6.204897268186363, "net_margin": -0.4041353761903803, "operating_margin": -0.404450091182576, "revenue_growth_yoy": 0.3383351911257087, "roa_avg2y": -0.11685526075712473, "roa_period_end": -0.10823063275362417, "roe_avg2y": -0.7079503267003266, "roe_period_end": -0.7797905902606683 } }, { "accn": "0000874015-26-000115", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 45280000.0, "cash": 242077000.0, "eps_diluted": -3.04, "free_cash_flow": -546227000.0, "net_income": -453897000.0, "operating_cash_flow": -500947000.0, "operating_income": -475081000.0, "revenue": 705138000.0, "stockholders_equity": 588351000.0, "total_assets": 3003675000.0, "total_liabilities": 2415324000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.105243298643157, "net_margin": -0.6436995311556036, "operating_margin": -0.6737418774764656, "revenue_growth_yoy": -0.10475377929453168, "roa_avg2y": -0.1514568432734982, "roa_period_end": -0.1511138854902744, "roe_avg2y": -0.9310354376295463, "roe_period_end": -0.7714731512311528 } }, { "accn": "0000874015-26-000115", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 23805000.0, "cash": 399266000.0, "eps_diluted": -2.56, "free_cash_flow": -331318000.0, "net_income": -366286000.0, "operating_cash_flow": -307513000.0, "operating_income": -353730000.0, "revenue": 787647000.0, "stockholders_equity": 386686000.0, "total_assets": 2990072000.0, "total_liabilities": 2603386000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 6.732558199676223, "net_margin": -0.4650382722209315, "operating_margin": -0.44909712091838094, "revenue_growth_yoy": 0.3409793195736226, "roa_avg2y": -0.13261746852070294, "roa_period_end": -0.12250072907943353, "roe_avg2y": -0.7634354030386432, "roe_period_end": -0.9472440171094894 } }, { "accn": "0000874015-26-000115", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 15721000.0, "cash": 276472000.0, "eps_diluted": -1.9, "free_cash_flow": -290091000.0, "net_income": -269722000.0, "operating_cash_flow": -274370000.0, "operating_income": -410191000.0, "revenue": 587367000.0, "stockholders_equity": 572887000.0, "total_assets": 2533876000.0, "total_liabilities": 1960989000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.4229944125106697, "net_margin": -0.45920523284420134, "operating_margin": -0.6983555426164562, "revenue_growth_yoy": -0.2752635553318132, "roa_avg2y": -0.10483666908557776, "roa_period_end": -0.10644640858510834, "roe_avg2y": -0.4011857589928486, "roe_period_end": -0.470811870403762 } }, { "accn": "0000874015-25-000089", "filed": "2025-02-19", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11955000.0, "cash": 869191000.0, "eps_diluted": -0.2, "free_cash_flow": 18844000.0, "net_income": -28597000.0, "operating_cash_flow": 30799000.0, "operating_income": -30186000.0, "revenue": 810456000.0, "stockholders_equity": 771737000.0, "total_assets": 2611690000.0, "total_liabilities": 1839953000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.3841710323594696, "net_margin": -0.03528507408175151, "operating_margin": -0.037245698717758895, "revenue_growth_yoy": 0.11133416705061541, "roa_avg2y": -0.011435495141903989, "roa_period_end": -0.01094961500024888, "roe_avg2y": -0.03775134173234791, "roe_period_end": -0.03705536989933099 } }, { "accn": "0000874015-24-000116", "filed": "2024-02-21", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 35120000.0, "cash": 397664000.0, "eps_diluted": -3.18, "free_cash_flow": 772000.0, "net_income": -444263000.0, "operating_cash_flow": 35892000.0, "operating_income": -172082000.0, "revenue": 729264000.0, "stockholders_equity": 743282000.0, "total_assets": 2389755000.0, "total_liabilities": 1646473000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.215139072384371, "net_margin": -0.609193652778692, "operating_margin": -0.2359666732486452, "revenue_growth_yoy": -0.35037889754043966, "roa_avg2y": -0.15802009899931832, "roa_period_end": -0.185903157436641, "roe_avg2y": -0.4012534456659574, "roe_period_end": -0.5977045051541676 } }, { "accn": "0000874015-22-000079", "filed": "2022-02-25", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 30905000.0, "cash": 683287000.0, "eps_diluted": 1.9, "free_cash_flow": 314722000.0, "net_income": 278143000.0, "operating_cash_flow": 345627000.0, "operating_income": 365883000.0, "revenue": 1122599000.0, "stockholders_equity": 1471094000.0, "total_assets": 3233112000.0, "total_liabilities": 1548565000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0526621684270345, "net_margin": 0.24776701208534838, "operating_margin": 0.3259249295607782, "revenue_growth_yoy": 0.872015461734209, "roa_avg2y": 0.09427144623460573, "roa_period_end": 0.08602949727692699, "roe_avg2y": 0.22082088050324453, "roe_period_end": 0.1890722142840634 } }, { "accn": "0000874015-21-000056", "filed": "2021-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13608000.0, "cash": 278820000.0, "eps_diluted": 2.07, "free_cash_flow": 589298000.0, "net_income": 273741000.0, "operating_cash_flow": 602906000.0, "operating_income": -61372000.0, "revenue": 599674000.0, "stockholders_equity": 1048079000.0, "total_assets": 2667784000.0, "total_liabilities": 1480624000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.4127026684057213, "net_margin": 0.4564830224421936, "operating_margin": -0.10234227263479824, "revenue_growth_yoy": 0.16627477979458516, "roa_avg2y": 0.13719434725669943, "roa_period_end": 0.1026098814596684, "roe_avg2y": 0.41192182331998084, "roe_period_end": 0.2611835558197426 } }, { "accn": "0001140361-20-004500", "filed": "2020-03-02", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 34764000.0, "cash": 129630000.0, "eps_diluted": 0.15, "free_cash_flow": 139385000.0, "net_income": 346000.0, "operating_cash_flow": 174149000.0, "operating_income": 31047000.0, "revenue": 514179000.0, "stockholders_equity": 281013000.0, "total_assets": 1322774000.0, "total_liabilities": 957494000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.4072943244618576, "net_margin": 0.0006729174081399668, "operating_margin": 0.06038169586855939, "revenue_growth_yoy": 0.3793243127239951, "roa_avg2y": 0.0003095863041166478, "roa_period_end": 0.00026157151561793625, "roe_avg2y": 0.0018182869214720767, "roe_period_end": 0.0012312597637831701 } }, { "accn": "0000874015-19-000045", "filed": "2019-03-01", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7107000.0, "cash": 84685000.0, "eps_diluted": -0.5, "free_cash_flow": -119212000.0, "net_income": -60400000.0, "operating_cash_flow": -112105000.0, "operating_income": -20160000.0, "revenue": 372776000.0, "stockholders_equity": 99565000.0, "total_assets": 912467000.0, "total_liabilities": 812902000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 8.164535730427358, "net_margin": -0.16202759834324099, "operating_margin": -0.054080734811253944, "roa_period_end": -0.06619417469344097, "roe_period_end": -0.6066388791241902 } } ], "latest_filing": { "accn": "0000874015-26-000115", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000874015.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000874015.json" }, "ticker": "IONS" }